“As the global spread of COVID-19 escalates and local and national governments enhance restrictions on people’s movements, we wish to reassure you that, as a result of the essential nature of the work we carry out, Galen will continue to conduct our critical business operations in all of our locations.
We are constantly monitoring the rapidly changing situation and continue to take guidance from governments and health officials to ensure our processes, policies and procedures are adapted as required.
The health and safety of our employees and our ability to ensure the delivery of medicines to patients is, and always has been, our top priority and we are committed to ensure this continues.
As the Coronavirus outbreak escalated Galen’s business continuity plan moved into a further phase, with the following actions being taken:
All of this has been done to ensure that we continue to offer our clients an uninterrupted and unhindered level of service. We fully appreciate the criticality of maintaining global supply chains. Our teams are fully appraised of all actions and changes required and are committed to keeping you informed at all stages during this outbreak.
Should you have any additional concerns regarding your partnership with Galen, please do not hesitate to contact your Galen representative.
Please continue to check this page for the latest information as this global situation continues to evolve.”
Should you have any additional concerns regarding your partnership with Galen, please do not hesitate to contact your Galen representative.
Upon declaration by the World Health Organisation (WHO) of the COVID-19 (Coronavirus) epidemic (now pandemic) in late January, Galen has been continually monitoring the situation relating to the global outbreak and its potential effect to our operations and employees, patients and clients.
That is why meeting client obligations is a fundamental priority to Galen, while ensuring the utmost safety in doing so for all of our employees.
The effectiveness of our Business Continuity Plan (BCP) processes have been continually monitored (and adjusted) to minimise any potential impact this pandemic would have to our worldwide operations.
We are following all local government guidance and best practice. As a qualifying essential business, we are operating across all our sites globally.
Yes. Galen is at the forefront of the development, marketing and distribution of essential medicines to vulnerable patients across the globe. By providing this support, Galen is recognised as an “essential” or “life-sustaining” business.
We can therefore confirm Galen will remain operational and our staff will be available to support your supply chain. We will continue to conduct our critical business operations and our facilities remain open.
Galen’s business continuity plans have been in place and enacted for some weeks and service levels have not been impacted. As a global business, we are proactive. To ensure the integrity of our supply and the safety of our staff, the following measures have been implemented:
All of this has been done to ensure that we continue to offer our clients an uninterrupted and unhindered level of service.
Access to Galen facilities is severely limited and we are currently restricting visitors on all our sites globally. Our employees are currently using alternative methods to conduct client meetings (i.e. virtual communication tools, videos etc.) whenever feasible. Should you wish to discuss a potential visit, please contact your Galen representative.
Should you have any additional concerns regarding your partnership with Galen, please do not hesitate to contact your Galen representative.
If you would like to explore how our expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.
Galen Limited
Seagoe Industrial Estate
Craigavon
BT63 5UA
United Kingdom
Telephone:+44 (0)28 3833 4974
Fax:+44 (0)28 3835 0206
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Galen US Inc
2661 Audubon Road
Audubon
PA 19403
United States of America
Telephone:+1 855-425-3646 (855-GALENINC)
Fax:+1 (215) 660 8501
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.